Cargando…

Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours

BACKGROUND: Bone metastases are associated with a worse outcome in patients with neuroendocrine tumours (NETs). Tumour overexpression of C-X-C chemokine receptor 4 (CXCR4) appears predictive of skeletal involvement. We investigated the role of circulating tumour cells (CTCs) and CXCR4 expression on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rizzo, Francesca M., Vesely, Clare, Childs, Alexa, Marafioti, Teresa, Khan, Mohid S., Mandair, Dalvinder, Cives, Mauro, Ensell, Leah, Lowe, Helen, Akarca, Ayse U., Luong, TuVinh, Caplin, Martyn, Toumpanakis, Christos, Krell, Daniel, Thirlwell, Christina, Silvestris, Franco, Hartley, John A., Meyer, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353867/ https://www.ncbi.nlm.nih.gov/pubmed/30636773 http://dx.doi.org/10.1038/s41416-018-0367-4

Ejemplares similares

Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours
por: Childs, Alexa, et al.
Publicado: (2016)

Management Strategies and Outcomes for Small Intestinal Neuroendocrine Tumours with Involvement of the Superior Mesenteric Vessels: A Systematic Review
por: Kmiotek, Elizabeth, et al.
Publicado: (2023)

Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasms
por: Childs, Alexa, et al.
Publicado: (2021)

Clinicopathological correlations of mesenteric fibrosis and evaluation of a novel biomarker for fibrosis detection in small bowel neuroendocrine neoplasms
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2019)

Circulating tumour cells and tumour biomarkers in functional midgut neuroendocrine tumours
por: Meyer, Tim, et al.
Publicado: (2022)

Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
por: Vesely, Clare, et al.
Publicado: (2022)

Appendiceal Goblet Cell Carcinoid Tumour: A Case of Unexpected Lung Metastasis
por: Pericleous, Marinos, et al.
Publicado: (2012)

Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2020)

What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?
por: Ratnayake, Gowri M., et al.
Publicado: (2022)

Pancreatic Adenocarcinoma in a Patient With Multiple Endocrine Neoplasia 1 Syndrome
por: Karpathakis, Anna, et al.
Publicado: (2013)

Prostate cancer and the influence of dietary factors and supplements: a systematic review
por: Mandair, Dalvinder, et al.
Publicado: (2014)

Diagnostic features and management options for duodenal neuroendocrine neoplasms: a retrospective, multi-centre study
por: Mandair, Dalvinder, et al.
Publicado: (2022)

Transcriptomic Profiling of In Vitro Tumor-Stromal Cell Paracrine Crosstalk Identifies Involvement of the Integrin Signaling Pathway in the Pathogenesis of Mesenteric Fibrosis in Human Small Intestinal Neuroendocrine Neoplasms
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2021)

Predictors of antiproliferative effect of lanreotide autogel in advanced gastroenteropancreatic neuroendocrine neoplasms
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2019)

Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours
por: Pipinikas, Christodoulos P, et al.
Publicado: (2015)

Predictive factors of antiproliferative activity of octreotide LAR as first-line therapy for advanced neuroendocrine tumours
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2016)

Gastric Mixed Adenoneuroendocrine Carcinoma with a Trilineage Cell Differentiation: Case Report and Review of the Literature
por: Pericleous, Marinos, et al.
Publicado: (2012)

Endoscopic ultrasound-guided fine-needle aspiration vs fine-needle biopsy for the diagnosis of pancreatic neuroendocrine tumors
por: Eusebi, Leonardo H., et al.
Publicado: (2019)

Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma
por: Fessas, Petros, et al.
Publicado: (2021)

Chromosome 18 Loss of Heterozygosity in Small Intestinal Neuroendocrine Tumours: Multi-Omic and Tumour Composition Analyses
por: Waterfield, Scott, et al.
Publicado: (2023)

Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module)
por: Ramage, John K., et al.
Publicado: (2022)

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
por: Turner, N C, et al.
Publicado: (2010)

922P EACH: A phase II study evaluating the safety and anti-tumour activity of avelumab and cetuximab in recurrent/metastatic squamous cell carcinomas
por: Forster, M., et al.
Publicado: (2020)

Insulinoma: a quarter century of dietary control
por: Boharoon, Hessa, et al.
Publicado: (2022)

Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs
por: Li, Su-Chen, et al.
Publicado: (2015)

Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer
por: Pearce, David R., et al.
Publicado: (2023)

Use of [(177)Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study
por: Glover, Matthew, et al.
Publicado: (2021)

A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms
por: Khan, M S, et al.
Publicado: (2013)

Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression
por: Di Domenico, Annunziata, et al.
Publicado: (2020)

The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients
por: Cives, Mauro, et al.
Publicado: (2022)

Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study
por: Caplin, Martyn E, et al.
Publicado: (2016)

Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: A systematic review
por: Khan, Mohid S, et al.
Publicado: (2020)

Matching-adjusted indirect treatment comparison of [(177)Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [(177)Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumours
por: Khan, Mohid S., et al.
Publicado: (2021)

Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study
por: Caplin, Martyn E., et al.
Publicado: (2020)

NETs: organ-related epigenetic derangements and potential clinical applications
por: Cives, Mauro, et al.
Publicado: (2016)

Tumour-To-Tumour Metastasis
por: Salm, R.
Publicado: (1975)

Tumour to Tumour Metastasis of Malignant Melanoma to Intracranial Tumour
por: Shariff, Zakir, et al.
Publicado: (2009)

Pediatric tumours: liver tumours
por: Towbin, Alexander J
Publicado: (2014)

Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3(rd)-line treatment
por: Lamarca, Angela, et al.
Publicado: (2021)

Pan-cancer deconvolution of tumour composition using DNA methylation
por: Chakravarthy, Ankur, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8nvjm3v1hia8mld36g1krs7ca1